COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 70 filers reported holding COGENT BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,268,754 | -17.7% | 5,566,026 | 0.0% | 6.34% | -14.4% |
| Q2 2023 | $65,901,748 | +28.0% | 5,566,026 | +16.6% | 7.41% | -5.5% |
| Q1 2023 | $51,494,423 | +103014.6% | 4,772,421 | +10.5% | 7.84% | +4.2% |
| Q4 2022 | $49,939 | -99.9% | 4,319,940 | 0.0% | 7.53% | -27.4% |
| Q3 2022 | $64,454,000 | +44.5% | 4,319,940 | -12.6% | 10.36% | +9.9% |
| Q2 2022 | $44,601,000 | +70.1% | 4,944,708 | +41.2% | 9.43% | +61.0% |
| Q1 2022 | $26,221,000 | +34.0% | 3,500,768 | +53.5% | 5.86% | +29.2% |
| Q4 2021 | $19,574,000 | +21.7% | 2,281,315 | +19.3% | 4.53% | +6.9% |
| Q3 2021 | $16,084,000 | +45.0% | 1,912,511 | +39.8% | 4.24% | +9.8% |
| Q2 2021 | $11,091,000 | -0.5% | 1,367,582 | +7.8% | 3.86% | -13.0% |
| Q1 2021 | $11,144,000 | +30.6% | 1,269,195 | +67.0% | 4.44% | -4.3% |
| Q4 2020 | $8,535,000 | – | 760,025 | – | 4.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,631,042 | $54,902,659 | 8.08% |
| Saturn V Capital Management LP | 1,775,415 | $17,310,296 | 7.24% |
| COMMODORE CAPITAL LP | 5,566,026 | $54,268,754 | 6.34% |
| New Leaf Venture Partners, L.L.C. | 501,530 | $4,889,918 | 6.28% |
| VR Adviser, LLC | 4,684,167 | $45,670,628 | 4.81% |
| Fairmount Funds Management LLC | 3,558,975 | $34,700,006 | 4.18% |
| Kynam Capital Management, LP | 2,210,125 | $21,548,719 | 3.52% |
| Vivo Capital, LLC | 2,244,941 | $21,888,175 | 2.40% |
| 5AM Venture Management, LLC | 790,440 | $7,706,790 | 2.22% |
| Ghost Tree Capital, LLC | 650,000 | $6,337,500 | 2.08% |